Alpheus Medical, Inc
Biotechnology ResearchMinnesota, United States11-50 Employees
Alpheus Medical, Inc. is a privately held biotechnology company based in Chanhassen, Minnesota, focused on oncology research. It is developing an investigational therapy that couples a tumor-accumulating drug with low-intensity ultrasound to activate treatment directly within solid tumor cells, aiming to limit systemic exposure. The approach, described in recent disclosures as Porphyrin Metabolite Activation, leverages a molecule that concentrates in tumors and is activated by ultrasound to produce localized pharmacologic effects. The company’s lead program targets glioblastoma and is being evaluated in clinical studies under regulatory oversight. With a small to mid-sized team, Alpheus Medical positions itself within the biotechnology research space pursuing a non-invasive, drug-centered modality for solid tumors.